## **Core Concept**
Theophylline is a methylxanthine drug used in therapy for respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma. Its levels can be influenced by various drugs that affect its metabolism, primarily through the cytochrome P450 enzyme system, specifically CYP1A2 and to a lesser extent CYP3A4.

## **Why the Correct Answer is Right**
The correct answer, , involves drugs known to affect theophylline levels. Theophylline is primarily metabolized by CYP1A2. Drugs that inhibit CYP1A2 can increase theophylline levels, potentially leading to toxicity. Common inhibitors include cimetidine, ciprofloxacin, and other fluoroquinolones. Among the options provided, if includes drugs like ciprofloxacin or cimetidine, these would be correct because they are known to inhibit CYP1A2, thereby decreasing the metabolism of theophylline and increasing its plasma levels.

## **Why Each Wrong Option is Incorrect**
- **Option A:** If this option includes drugs that are primarily CYP3A4 inhibitors (like ketoconazole, erythromycin) without significant effect on CYP1A2, they would have a minimal effect on theophylline levels. Theophylline's metabolism is less dependent on CYP3A4 compared to CYP1A2.
- **Option B:** If this option includes drugs known to induce CYP1A2 (like rifampicin, phenobarbital), they would increase the metabolism of theophylline, thereby decreasing its levels, not increasing them.
- **Option D:** If this option includes drugs with no significant interaction with theophylline's metabolism or drugs that might have variable effects (e.g., some antacids), they would not significantly increase theophylline levels.

## **Clinical Pearl / High-Yield Fact**
A critical clinical pearl is to monitor theophylline levels when co-administering drugs known to affect CYP1A2, as this can help prevent theophylline toxicity, which presents with symptoms such as nausea, vomiting, palpitations, and in severe cases, seizures.

## **Correct Answer: C.**